BiWaze cough system receives 510(k) clearanceMay 9, 2020
ABM Respiratory Care has received 510(k) clearance to market its BiWaze cough therapy system.
BiWaze helps remove secretions for people unable to cough or clear secretions effectively due to reduced peak cough flow resulting from high spinal cord injury, neuromuscular deficits or severe fatigue associated with intrinsic lung disease.
The system is the smallest and lightest assisted cough device on the market, according to the company.
The system provides a non-invasive solution to clear secretions from the upper airways as compared to invasive suctioning. It also provides high-frequency oscillations to break up thick secretions and help remove them from the lungs. Each therapy cycle can be personalised to provide the most effective therapy for a person’s respiratory condition.